1472 results
Patient risk factors and outcome in contemporary TAVI
17 May 2022 – From EuroPCR 2022
Watch these videos to learn more about the patient's risk factors and outcome after TAVI in various situations: with atrial fibrillation and history of PCI, with Diabetes Mellitus, with aortic stenosis based on cardiac damage, and more!
EuroPCR 2022 Early experience and registry results in TAVI: Optimize PRO, FORWARD PRO, Neo-Align, and more!
17 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in TAVI! ACURATE neo2 post-procedural hemodynamic outcomes, first real-world results of the JenaValve TAVI system, Optimize PRO study, a next-generation aortic transcatheter heart valve, commissural alignment, and three-year outcomes following TAVI with a self-expanding valve with pericardial wrap.
Double jeopardy: coronary disease in patients undergoing TAVI
17 May 2022 – From EuroPCR 2022
Through the presentation of real-life clinical cases, this session will allow you to discover the use of ALLEGRA for valve-in-valve TAVI, understand the management of coronary artery disease in TAVI patients, better detect when and how to protect coronary arteries during TAVI, or even learn how...
Valve-in-valve: the journey starts with the first prosthesis
17 May 2022 – From EuroPCR 2022
In this EuroPCR 2022 session featuring Philip Maccarthy, Julia Mascherbauer, Hendrik Treede, Christian Hengstenberg, Radoslaw Parma, and Giuseppe Tarantini, analyze the impact of valve-in-valve interventions on lifetime management, learn about particular clinical considerations and the procedural technique of TAVI-in-TAVI procedures, and appreciate the potential pitfalls of...
Lifetime management of patients with severe aortic stenosis - Securing long-term benefits
17 May 2022 – From EuroPCR 2022
Watching this EuroPCR 2022 session on lifetime management of patients with aortic stenosis will help you understand the importance of the heart team in patient specific treatment and how procedural refinement may optimise long-term outcomes.
Reducing permanent pacemaker implantation for TAVI: techniques to optimise patient outcomes
17 May 2022 – From EuroPCR 2022
Lars Søndergaard, Won-Keun Kim, and Christophe Saint Etienne came together for EuroPCR 2022 to share their experience of implanters achieving single-digit permanent pacemaker implantation: learn about the latest technique and new product features to reduce permanent pacemaker implantation.
View more videos and course resources here!
Worldwide experiences on contemporary TAVI implantation technique with Evolut platform
17 May 2022 – From EuroPCR 2022
Through this discussion between Yohei Ohno, Kendra Grubb, and Stefan James recorded for EuroPCR 2022, discover recent updates on the COT experience/studies (optimize PRO 400pts, OCEAN TAVI, personal experience), find out about key success factors/steps on the technique to achieve optimal results, and learn how to...
How to manage patients with coronary artery disease and aortic stenosis? The PRIME CLASS study
17 May 2022 – From EuroPCR 2022
Thanks to this interview between Enrique Gutierrez Ibanez and Nicolas Meneveau shot for EuroPCR 2022, be aware of the clinical evidence and the studies currently ongoing for the “coronary artery disease and aortic stenosis” clinical setting, learn more about the current approach to diagnose and treat...
Hemodynamics and minimalist TAVI - how does it fit?
17 May 2022 – From EuroPCR 2022
Watch this presentation by Thomas Modine for EuroPCR 2022 to hear about the multimodality approach to optimise TAVI procedure and its impact on post-operative course, to get an update on how minimalist TAVI can be performed successfully in most patients without conversion to general anaesthesia, and...
DurAVR THV: a valve designed for life
17 May 2022 – From EuroPCR 2022
Watch this discussion between Christopher Meduri and Vinayak Bapat to understand the features of the DurAVR THV, a transcatheter aortic valve designed to last longer and work better for lifetime management of aortic stenosis patients due to its unique leaflet design that shows clear haemodynamic advantages...
CoreValve™ and Evolut™ TAVI systems
13 May 2022
Sponsored by Medtronic
CHOICE CLOSURE - Proven benefits from a randomised trial of suture-based closure device strategy for transfemoral transcatheter aortic valve replacement
17 May 2022 – From EuroPCR 2022
Watch this presentation of the CHOICE CLOSURE trial proposed by Mohamed Abdel-Wahab for EuroPCR 2022 to understand the benefits of suture-based strategy in terms of access-site or access-related major and minor vascular complications, to compare suture-based to plug-based closure in large-bore arterial access, and to analyze...
Transcaval versus transaxillary TAVR in contemporary practice - a propensity-weighted analysis
09 May 2022
As there has been no systematic comparison of transcaval and transaxillary access so far, the present study aimed to compare these two approaches with each other, as well as with transfemoral access.
Reviewer
Reviewer
A case of severe aortic stenosis and severe calcified ostial RCA disease
01 Jun 2022
Techniques to manage simultaneously severe calcified aortic stenosis and severe heavily calcified ostial RCA disease combining TAVI and ROTABLATION.
Author
Author
Crash TAVI-in-TAVI complicated by coronary obstruction
20 Apr 2022
Thanks to this Image in Interventional Cardiology, view an emergency TAVI-in-TAVI for cardiogenic shock secondary to acute valve degeneration complicated by left main stem obstruction treated successfully by chimney stenting.
Insights from the Corevalve US Pivotal and SURTAVI trials
05 Apr 2022
Pierre Deharo and Giuseppe Di Gioia provide their take on this analysis of the 5 years incidence, outcomes and predictors of hemodynamic SVD in patients undergoing TAVI and surgery from the Corevalve US Pivotal and SURTAVI trials.
Author
Author
Restriction in supra-annular transcatheter heart valve leaflet mobility during coronary access after valve-in-valve TAVI
05 Apr 2022
This Image in Interventional Cardiology highlights how patient-specific ex vivo simulations offer physicians the opportunity to observe and evaluate the potential in vivo impact of different techniques particularly for complex structural heart interventions.
No go (again) for oral anticoagulation after TAVR: Results of the ADAPT-TAVR trial
04 Apr 2022
Francesco Costa analyses the results of ADAPT-TAVR, a prospective randomized trial on edoxaban vs dual antiplatelet therapy for valve thrombosis and cerebral thromboembolism after transcatheter aortic-valve replacement.
Author
PCRonline @ ACC 2022 Scientific Sessions
29 Mar 2022
Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2022 Scientific Sessions #ACC22.
How should I treat? - TAVI in bicuspid aortic valve stenosis: tips and tricks for an optimal result
06 Apr 2022
A 70-year-old male patient was referred to hospital with signs of acute myocardial infarction. Echocardiography confirmed impaired left ventricular function and severe low flow, low gradient aortic valve stenosis. Would you go for surgical aortic valve replacement or transfemoral TAVI?
Author
Author
Author
Author
Author
